{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:03:47Z","timestamp":1787670227612,"version":"build-2736575974"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:00:00Z","timestamp":1529971200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA031056-03"],"award-info":[{"award-number":["R01DA031056-03"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01469","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:38:14Z","timestamp":1529973494000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Immune Activation, Proinflammatory Cytokines, and Conventional Risks for Cardiovascular Disease in HIV Patients: A Case-Control Study in Bahia, Brazil"],"prefix":"10.3389","volume":"9","author":[{"given":"Clara","family":"Brites-Alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estela","family":"Luz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo M.","family":"Netto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thalis","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Sohbie","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Pedroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Brites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study","volume":"43","author":"Palella","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/1741-7015-11-251","article-title":"Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy?","volume":"11","author":"Sabin","year":"2013","journal-title":"BMC Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/QAI.0000000000000018","article-title":"Life expectancy in the immune recovery era: the evolving scenario of the HIV epidemic in northern Italy","volume":"65","author":"Guaraldi","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B4","unstructured":"Boletim Epidemiol\u00f3gico \u2013 Aids e IST Ano V \u2013 no 12017"},{"key":"B5","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S1473-3099(15)00056-0","article-title":"Future challenges for clinical care of an ageing population infected with HIV: a modelling study","volume":"15","author":"Smit","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/cid\/cir626","article-title":"Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study","volume":"53","author":"Hasse","year":"2011","journal-title":"Clin Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1093\/infdis\/jix518","article-title":"Comorbidities among US patients with prevalent HIV infection \u2013 a trend analysis","volume":"216","author":"Gallant","year":"2017","journal-title":"J Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e59768","DOI":"10.1371\/journal.pone.0059768","article-title":"Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era","volume":"8","author":"Grinsztejn","year":"2013","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.2105\/AJPH.2012.300844","article-title":"HIV infection and older Americans: the public health perspective","volume":"102","author":"Brooks","year":"2012","journal-title":"Am J Public Health"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/cid\/cix998","article-title":"Multimorbidity among persons living with HIV in the U.S","volume":"66","author":"Wong","year":"2018","journal-title":"Clin Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e95061","DOI":"10.1371\/journal.pone.0095061","article-title":"Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy","volume":"9","author":"Miller","year":"2014","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.amjcard.2015.10.030","article-title":"Patterns of cardiovascular mortality for HIV-infected adults in the United States: 1999 to 2013","volume":"117","author":"Feinstein","year":"2016","journal-title":"Am J Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1210\/jc.2006-2190","article-title":"Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease","volume":"92","author":"Triant","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e46143","DOI":"10.1371\/journal.pone.0046143","article-title":"Acute plasma biomarkers of T-cell activation set-point levels and of disease progression in HIV-1 infection","volume":"7","author":"Liovat","year":"2012","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e8886","DOI":"10.1371\/journal.pone.0008886","article-title":"Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease","volume":"5","author":"Naeger","year":"2010","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/QAI.0b013e3181f4b752","article-title":"Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system","author":"Triant","year":"2010","journal-title":"J Acquir Imune Defic Syndr"},{"key":"B17","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/blood.V95.10.3191","article-title":"Alterations of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome","volume":"95","author":"Ledru","year":"2000","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0950-351X(05)80302-7","article-title":"Steroid hormone, cytokine, lipid and metabolic disturbances in HIV infections","volume":"8","author":"Nunez","year":"1994","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1210\/endo-125-1-267","article-title":"Multiple cytokines stimulate hepatic lipid synthesis in vivo","volume":"125","author":"Feingold","year":"1989","journal-title":"Endocrinology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP171764.GL","article-title":"American Association of Clinical Endocrinologists and American College of endocrinology guidelines for the management of dyslipidemia and prevention of cardiovascular disease","volume":"23","author":"Jellinger","year":"2017","journal-title":"Endocr Pract"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"Kuller","year":"2008","journal-title":"PLoS Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cytogfr.2007.04.002","article-title":"How TNF was recognized as a key mechanism of disease","volume":"18","author":"Clark","year":"2007","journal-title":"Cytokine Growth Factor Rev"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e0144312","DOI":"10.1371\/journal.pone.0144312","article-title":"Elevated biomarkers of inflammation and coagulation in patients with HIV are associated with higher Framingham and VACS risk index scores","volume":"10","author":"Mooney","year":"2015","journal-title":"PLoS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2337\/diab.41.2.S97","article-title":"Role of cytokines in inducing hyperlipidemia","volume":"41","author":"Feingold","year":"1992","journal-title":"Diabetes"},{"key":"B25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.plipres.2011.04.002","article-title":"Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy","volume":"50","author":"McLaren","year":"2011","journal-title":"Prog Lipid Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.4049\/jimmunol.168.7.3195","article-title":"IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking","volume":"168","author":"Dufour","year":"2002","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cyto.2011.10.020","article-title":"High plasma CXCL10 levels are associated with HCV-genotype 1, and higher insulin resistance, fibrosis, and HIV viral load in HIV\/HCV coinfected patients","volume":"57","author":"Berenguer","year":"2012","journal-title":"Cytokine"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.jhep.2014.07.006","article-title":"CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis","volume":"61","author":"Zhang","year":"2014","journal-title":"J Hepatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01469\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T19:56:25Z","timestamp":1571514985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01469\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,26]]},"references-count":28,"alternative-id":["10.3389\/fimmu.2018.01469"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01469","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,26]]},"article-number":"1469"}}